browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
a80b2b24-ba49-4e81-90b4-f4f1cd0ff9b5
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 18:28:54
Income (reported)
—
Expenses (reported)
$420,000
Expenses method
A
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

BRIDGEBIO PHARMA, INC.

Contact
AMANDA MALAKOFF
Phone
+1 202-543-8345
Address
zip:94304, city:Palo Alto, state:CA, street:3160 Porter Drive Suite 250
Client

BRIDGEBIO PHARMA, INC.

Biotech company

State
CA
Country
US
Effective date
2023-10-11
Issues lobbied + lobbyists (1)

PHA — Pharmacy

H.R.7148 - Consolidated Appropriations Act, 2026 Give Kids a Chance Act of 2025 - H.R. 1262; S 932 Orphan drug policies General issues and provisions related to PBM Reform

Lobbyists:
  • AMANDA MALAKOFF
  • TRIPP ADAMS — covered position: Staff Assistant and Legislative Correspondent for Sen. Johnny Isakson; Legislative Correspondent for Sen. Kelly Loeffler; Health Research Assistant and Staff Member for the Senate Health, Education, Labor and Pensions Committee. [new]

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.